Cipremi RTU Injection 20 ml
Cipla Ltd
PARENTERAL
In Stock
Cipremi RTU Injection 20 ml belongs to a group of anti-viral medicines called SARS-CoV-2 nucleotide analogue RNA polymerase inhibitor used to treat coronavirus disease requiring hospitalisation. Coronavirus disease, also known as SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus 2), is an infectious disease caused by the corona virus.
Cipremi RTU Injection 20 ml contains ‘Remdesivir, which binds to the viral-RNA dependant RNA polymerase enzyme, an enzyme that helps the coronavirus to replicate itself. This inhibits viral replication by premature termination of RNA transcription. Thereby, Cipremi RTU Injection 20 ml lowers the virus load in the body and helps treat the infection.
Cipremi RTU Injection 20 ml will be administered by a healthcare professional in a hospital or a healthcare setting capable of providing in-patient hospital care. In some cases, you may experience certain side effects such as nausea, increased transaminase levels, and increased prothrombin time. You are advised to talk to your doctor if you experience these side effects persistently.
Consult your doctor if you are pregnant, think you are pregnant or breastfeeding. The safety of and effectiveness of Cipremi RTU Injection 20 ml in children below 12 years has not been established yet. Transaminase levels should be monitored before and during the treatment with Cipremi RTU Injection 20 ml. Keep your doctor informed about your health condition and the medicines you are taking to prevent any side effects/interactions.
Coronavirus disease (COVID 19).
Cipremi RTU Injection 20 ml belongs to a group of anti-viral medicines called SARS-CoV-2 nucleotide analogue RNA polymerase inhibitor. Cipremi RTU Injection 20 ml is used to treat corona virus disease requiring hospitalisation. Cipremi RTU Injection 20 ml binds to the viral-RNA-dependant RNA polymerase enzyme, an enzyme that helps the corona virus to replicate itself. This inhibits viral replication by premature termination of RNA transcription. Thereby, Cipremi RTU Injection 20 ml lowers virus load in the body and helps treat the infection.
Do not take Cipremi RTU Injection 20 ml if you are allergic to any of its contents. Inform your doctor if you have heart, liver or kidney problems. Consult your doctor before taking Cipremi RTU Injection 20 ml if you are pregnant, think you are pregnant or breastfeeding. Cipremi RTU Injection 20 ml is indicated for use only in patients above 12 years, weighing at least 40kg. The safety and effectiveness of Cipremi RTU Injection 20 ml in children below 12 years is unknown. Transaminase levels should be monitored before and during the treatment with Cipremi RTU Injection 20 ml. Treatment with Cipremi RTU Injection 20 ml should be discontinued if the ALT (Alanine aminotransferase) levels are greater than ten times the upper limit of normal. Keep your doctor informed about your health condition and the medicines you are taking to prevent any side effects/interactions.
Drug-Drug Interactions: Cipremi RTU Injection 20 ml may interact with antimalarials (chloroquine, hydroxychloroquine)
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interaction: Inform your doctor if you are at an increased risk of transaminase elevations and infusion-related reactions.
It is not known whether Cipremi RTU Injection 20 ml interacts with alcohol. Please consult your doctor.
There is insufficient data regarding the safety of Cipremi RTU Injection 20 ml during pregnancy. Please consult a doctor if you are pregnant or think you might be pregnant.
There is insufficient data regarding the passage of Cipremi RTU Injection 20 ml into breastmilk. Please consult a doctor if you are breastfeeding.
It is unknown if Cipremi RTU Injection 20 ml affects your ability to drive. Drive or operate machinery only if you are alert.
The effectiveness of Cipremi RTU Injection 20 ml in patients with liver impairment have not been evaluated. Please consult your doctor if you have a liver impairment or any concerns regarding this.
The effectiveness of Cipremi RTU Injection 20 ml in patients with kidney impairment have not been evaluated. Please consult your doctor if you have kidney impairment or any concerns regarding this.
The safety and effectiveness of Cipremi RTU Injection 20 ml in children below 12years is unknown.
This item is Not Returnable.
Expires on or after - Sep-23
COVID-19: Corona virus disease, also known as SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus 2) is an infectious disease caused by the corona virus. Corona virus belongs to a group of RNA viruses and has crown-like projections on the surface of the pathogen. The virus transmits through droplets generated from an infectious person’s cough, sneeze or heavy breathing. The common symptoms of corona virus disease are dry cough, breathlessness, shortness of breath, tiredness, fever, loss of sense of taste and smell, diarrhoea, body pains, headache and sore throat.
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
(Inclusive of all taxes)
Provide Delivery Location
Vial
20 ml Injection in 1 Vial